Chicago, IL, United States of America

Olesya Ulanovskaya

This inventor holds 1 USPTO granted patent. Top assignee: The University of Chicago. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Olesya Ulanovskaya. Retrieved from https://idiyas.com/inventor/olesya-ulanovskaya

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Olesya Ulanovskaya: Innovator in Pyrrolidinone Derivatives

Introduction

Olesya Ulanovskaya is a prominent inventor based in Chicago, IL (US). She has made significant contributions to the field of chemistry, particularly in the development of novel compounds that have potential applications in medical science.

Latest Patents

Ulanovskaya holds a patent for "Scaffold-diversified pyrrolidinone derivatives and their use." This patent presents novel compounds of the formula (I), where R, R, R, R, R, R, and R are defined in the detailed description. Two preferred compounds of formulae (IX) and (X) are disclosed. The patent also outlines the uses of these compounds, including their role in regulating glucose transport and inhibiting acetyl coenzyme A carboxylase.

Career Highlights

Olesya Ulanovskaya is affiliated with the University of Chicago, where she conducts her research and development work. Her innovative approach to chemistry has led to advancements that could impact various therapeutic areas.

Collaborations

Ulanovskaya collaborates with notable colleagues, including Sergey A Kozmin and Jiayue Cui, enhancing the research output and fostering a collaborative environment in her field.

Conclusion

Olesya Ulanovskaya's work in pyrrolidinone derivatives exemplifies the intersection of innovation and practical application in science. Her contributions are paving the way for future advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…